Impact of motion management strategies on abdominal organ at risk delineation for magnetic resonance-guided radiotherapy

被引:0
|
作者
Daly, Mairead [1 ]
McDaid, Lisa [2 ]
Anandadas, Carmel [3 ]
Brocklehurst, Andrew [3 ]
Choudhury, Ananya [1 ,3 ]
McWilliam, Alan [1 ,4 ]
Radhakrishna, Ganesh [1 ,3 ]
Eccles, Cynthia L. [1 ,2 ]
机构
[1] Univ Manchester, Fac Biol Med & Hlth, Div Canc Sci, Manchester M13 9PL, England
[2] Christie NHS Fdn Trust, Dept Radiotherapy, Manchester M20 4BX, England
[3] Christie Hosp NHS Fdn Trust, Dept Clin Oncol, Manchester M20 4BX, England
[4] Christie Hosp NHS Fdn Trust, Dept Med Phys & Engn, Manchester M20 4BX, England
关键词
Motion management; MR-guided radiotherapy; SABR; SBRT; IGRT; INTEROBSERVER VARIABILITY; VOLUME DELINEATION; MRI; SEGMENTATION; CANCER;
D O I
10.1016/j.phro.2024.100650
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: The impact of respiratory motion management strategies for abdominal radiotherapy, such as abdominal compression (AC) and breath hold (BH), on abdominal organ at risk (OAR) delineation on magnetic resonance imaging (MRI) is unknown. This feasibility study compared the inter- and intra- observer delineation variation on MRI acquired with AC, BH for three critical abdominal OAR. Materials and methods: T2-weighted (W) 3D MRI in free-breathing (FB) and with AC, and T1W 3D mDixon exhale BH were acquired. Four observers blinded to motion management strategy used, delineated stomach, liver, and duodenum on all MRI. One case per strategy was repeated over 6 weeks later to quantify intra-observer variation. Simultaneous truth and performance level estimation (STAPLE) contours for each OAR were generated, median and IQR mean distance to agreement (mDTA) and maximum Hausdorff distance (HD) between observer and STAPLE contours were calculated. Observers scored organ visibility on each MRI using a four-point Likert scale. Results: A total of 27 scans including repeats were delineated. Pooled mDTA for all OARs was 1.3 mm (0.5 mm) with AC, 1.4 mm (1.0 mm) with BH, and 1.3 mm (0.5 mm) in FB. Intra-observer mDTA was highest for all organs in FB with 10.8 mm for duodenum, 1.8 mm for liver, and 2.7 mm for stomach. The pooled mean perceptual quality score value was highest for AC across organs. Conclusions: No motion management strategy demonstrated superior similarity across OAR, emphasizing the need for personalised approaches based on individual clinical and patient factors.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases
    Werensteijn-Honingh, Anita M.
    Kroon, Petra S.
    Winkel, Dennis
    van Gaal, J. Carlijn
    Hes, Jochem
    Snoeren, Louk M. W.
    Timmer, Jaleesa K.
    Mout, Christiaan C. P.
    Bol, Gijsbert H.
    Kotte, Alexis N.
    Eppinga, Wietse S. C.
    Intven, Martijn
    Raaymakers, Bas W.
    Jurgenliemk-Schulz, Ina M.
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2022, 23 : 66 - 73
  • [2] A practical implementation of risk management for the clinical introduction of online adaptive Magnetic Resonance-guided radiotherapy
    Klueter, Sebastian
    Schrenk, Oliver
    Renkamp, Claudia Katharina
    Gliessmann, Stefan
    Kress, Melanie
    Debus, Juergen
    Hoerner-Rieber, Juliane
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2021, 17 : 53 - 57
  • [3] Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapy
    Sebastian Regnery
    Lukas Leiner
    Carolin Buchele
    Philipp Hoegen
    Elisabetta Sandrini
    Thomas Held
    Maximilian Deng
    Tanja Eichkorn
    Carolin Rippke
    C. Katharina Renkamp
    Laila König
    Kristin Lang
    Sebastian Adeberg
    Jürgen Debus
    Sebastian Klüter
    Juliane Hörner-Rieber
    Radiation Oncology, 18
  • [4] Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapy
    Regnery, Sebastian
    Leiner, Lukas
    Buchele, Carolin
    Hoegen, Philipp
    Sandrini, Elisabetta
    Held, Thomas
    Deng, Maximilian
    Eichkorn, Tanja
    Rippke, Carolin
    Renkamp, C. Katharina
    Koenig, Laila
    Lang, Kristin
    Adeberg, Sebastian
    Debus, Juergen
    Klueter, Sebastian
    Hoerner-Rieber, Juliane
    RADIATION ONCOLOGY, 2023, 18 (01)
  • [5] Magnetic Resonance-Guided Adaptive Radiotherapy: A Solution to the Future
    Kupelian, Patrick
    Sonke, Jan-Jakob
    SEMINARS IN RADIATION ONCOLOGY, 2014, 24 (03) : 227 - 232
  • [6] The ViewRay System: Magnetic Resonance-Guided and Controlled Radiotherapy
    Mutic, Sasa
    Dempsey, James F.
    SEMINARS IN RADIATION ONCOLOGY, 2014, 24 (03) : 196 - 199
  • [7] Reducing the Toxicity of Radiotherapy for Pancreatic Cancer With Magnetic Resonance-guided Radiotherapy
    Tchelebi, Leila T.
    Zaorsky, Nicholas G.
    Rosenberg, Jennifer C.
    Sharma, Navesh K.
    Tuanquin, Leonard C.
    Mackley, Heath B.
    Ellis, Rodney J.
    TOXICOLOGICAL SCIENCES, 2020, 175 (01) : 19 - 23
  • [8] Accuracy of deformable image registration-based intra-fraction motion management in Magnetic Resonance-guided radiotherapy
    Palacios, Miguel A.
    Gerganov, Georgi
    Cobussen, Paul
    Tetar, Shyama U.
    Finazzi, Tobias
    Slotman, Berend J.
    Senan, Suresh
    Haasbeek, Cornelis J. A.
    Kawrakow, Iwan
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2023, 26
  • [9] Online Magnetic Resonance-Guided Radiotherapy (oMRgRT) for Gynecological Cancers
    Portelance, Lorraine
    Corradini, Stefanie
    Erickson, Beth
    Lalondrelle, Susan
    Padgett, Kyle
    van der Leij, Femke
    van Lier, Astrid
    Jurgenliemk-Schulz, Ina
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Magnetic resonance-guided radiotherapy (MRgRT) for patients with lung cancer
    Crockett, Cathryn
    Chuter, Robert
    Cobben, David
    Dubec, Michael
    Green, Olga
    Hackett, Sara
    McDonald, Fiona
    Robinson, Clifford
    Samson, Pamela
    Shiarli, Anna-Maria
    Straza, Michael
    Verhoeff, Joost
    Vlacich, Gregory
    Werner-Wasik, Maria
    Faivre-Finn, Corinne
    LUNG CANCER, 2021, 156 : S62 - S62